Clinical Observation on 42 Cases of Perennial Allergic Rhinitis Treated by Sheti Zhiqiu Granules

Peng Shunlin~1; Zhong Qu~2; Yuan Xiaohui~1

doi:10.13288/j.11-2166/r.2004.11.025

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on 42 Cases of Perennial Allergic Rhinitis Treated by Sheti Zhiqiu Granules

更新时间：2021-11-20

- Clinical Observation on 42 Cases of Perennial Allergic Rhinitis Treated by Sheti Zhiqiu Granules
- Journal of Traditional Chinese Medicine Issue 11, Pages: 836-837(2004)
- 作者机构：
  
  1. 成都中医药大学
  2. 四川省绵阳市第四人民医院
  3. 成都中医药大学四川省成都市十二桥路37号,610075
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2004.11.025
  CLC： R276.1
- Published：2004
- 稿件说明：
移动端阅览
[1]彭顺林,钟渠,袁晓辉.摄涕止鼽颗粒治疗常年性变应性鼻炎42例临床观察[J].中医杂志,2004(11):836-837.

Peng Shunlin~1, Zhong Qu~2, Yuan Xiaohui~1. Clinical Observation on 42 Cases of Perennial Allergic Rhinitis Treated by Sheti Zhiqiu Granules[J]. Journal of Traditional Chinese Medicine2004, (11): 836-837.
[1]彭顺林,钟渠,袁晓辉.摄涕止鼽颗粒治疗常年性变应性鼻炎42例临床观察[J].中医杂志,2004(11):836-837. DOI： 10.13288/j.11-2166/r.2004.11.025.

Peng Shunlin~1, Zhong Qu~2, Yuan Xiaohui~1. Clinical Observation on 42 Cases of Perennial Allergic Rhinitis Treated by Sheti Zhiqiu Granules[J]. Journal of Traditional Chinese Medicine2004, (11): 836-837. DOI： 10.13288/j.11-2166/r.2004.11.025.

摘要

目的:观察摄涕止鼽颗粒治疗常年性变应性鼻炎（PAR）的疗效。方法:78例常年性变应性鼻炎患者随机分为两组

治疗组42例应用摄涕止鼽颗粒

对照组36例应用抗组胺药氯雷他定。结果:治疗组有效率为90.48%

对照组有效率为94.44%

两组疗效比较无显著性差异（P>0.05）;而治疗组远期疗效的有效率为84.21%

对照组的有效率为54.55%

两组远期疗效有显著性差异（P<0.05）。结论:摄涕止鼽颗粒为临床治疗PAR的有效制剂

且远期疗效稳定

优于西药。

Abstract

Objective: To observe the curative effect of Sheti Zhiqiu Granules on perennial allergic rhinitis （PAR）. Methods: 78 cases of PAR were randomly divided into 2 groups. The treatment group of 42 cases were treated by Sheti Zhiqiu Granules and the control group of 36 cases by antihistamin agent Loratadine. Results: The effective rate was 90. 48% in the treatment group and 94. 44% in the control group with no significantly difference between the two groups （P>0. 05）; The long-term effective rate was 84. 21% in the treatment group and 54. 55% in the control group with a significant difference between the two groups （P<0. 05）. Conclusion: Sheti Zhiqiu Granules is effective for clinical treatment of PAR

with a stable long-term therapeutic effect

superior to Loratatine.

关键词

Keywords

references

查看原文

Views

116

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Construction and Application of "Source-Pivot-Convergence" Pattern Identification and Treatment Model for Malignant Tumors

The Philosophy and Practical Pathway of "Dao （道）-Shen （神）-Formula" in Traditional Chinese Medicine

A Preliminary Discussion on the Method of Regulating Qi and Calming the Mind

Exploring the Comorbidity Mechanism，Prevention and Treatment Strategies of Rheumatoid Arthritis with Coronary Atherosclerotic Heart Disease Based on Collateral Disease Theory

Effect of Xiaoqinglong Decoction （小青龙汤） on Th2 Immune Responses and Nasal Mucosal TSLP/OX40L Pathway in Allergic Rhinitis Model Rats

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰